Single Use Bioreactors Market: Global Size, Share, Trends, Growth and Forecast, 2022-2032
Single Use Bioreactors Market Overview and Definition
The single use bioreactors market refers to the global market for bioreactors that are designed for single use, meaning they are disposed of after a single use. These bioreactors are used for the production of biopharmaceuticals, vaccines, and other biologics. Single use bioreactors offer several advantages over traditional stainless steel bioreactors, including lower capital costs, reduced cleaning and validation requirements, and increased flexibility.
The single use bioreactors market is driven by factors such as the increasing demand for biopharmaceuticals, the rising adoption of single use technologies, and the need for more efficient and cost-effective bioprocessing solutions. The market can be segmented based on product type, cell type, application, and geography.
The product type segment includes stirred tank bioreactors, wave-induced motion bioreactors, and others. The cell type segment includes mammalian cells, bacteria, yeast, and others. The application segment includes biopharmaceutical production, vaccine production, contract research and manufacturing, and others. Geographically, the market can be segmented into North America, Europe, Asia-Pacific, Middle East & Africa, and South America.
The key players in the single use bioreactors market include Thermo Fisher Scientific, Sartorius AG, GE Healthcare, Merck KGaA, Danaher Corporation, and Eppendorf AG. These companies offer a range of single use bioreactor products and services for various applications and industries.
The single use bioreactors market is highly competitive, with several large and small players offering a range of products and services. The market is characterized by the presence of several established players as well as new entrants. In recent years, there has been a growing trend towards the use of disposable technologies in bioprocessing, which is expected to drive the growth of the single use bioreactors market.
A single-use bioreactor or a disposable bioreactor is a bioreactor with a disposable bag instead of a culture vessel in which the lining in contact with the cell culture is plastic, and this lining is encased within a more permanent structure.
The utilization of SUBs holds several advantages over its conventional alternatives such as low initial capital, lower downtimes, high batch output. and as a result are replacing them. Also, these do not require cleaning or sterilization and can be disposed and replaced by new bags. This lowers the chances of cross-contamination which makes them more efficient and highly desirable. These are perfectly suitable to produce biopharmaceutical goods due to their high-performance characteristics and are already being deployed for high density cell culture and in the field of mammalian cell culture applications.
The global single use bioreactors market is expected to grow at a more than healthy CAGR in the years to follow.
The growth of this market is attributed towards major pertaining factors including the increasing usage of SUBs in the industrial and commercial sectors, rapid adoption of disposable technology in the pharmaceutical and biotechnological industries and in small companies and startups, increasing biopharmaceutical R&D and government support for them, increasing demand from the medical sector, reduced automation complexity, ease in the cultivation of marine organisms, the growing biologics market, and the technological advancements in SUBs.
Also, SUBs have applications ranging from academic to commercial-scale laboratories, in drug discovery, pharmaceutical, environmental, and life science, for the development of vaccines, antibodies, cell culture, biofuel manufacturing, and numerous others. As per reports, most biopharmaceutical manufacturers in the near future will adopt 100% fully disposables facilities in their operations. This will contribute massively to the growth of the market.
Moreover, SUBs embedded with improved sensors and higher operational flexibility for multi-drug production within less time increase trend toward the production of different drugs, using the same facility, in minimum time and with minimum costs. Consequently, high capacity disposable bioreactors are expected to replace conventional bioreactors in large-scale manufacturing facilities in the upcoming times. Furthermore, growing demand from emerging economies for personalized medicine, biopharmaceuticals, frequent launch of new products, and expected surge in biosimilar production in developed economies are anticiapted to propel the growth of the single-use bioreactor market.
More importantly, in the race to develop a vaccine against the ongoing coronavirus pandemic, many leading manufacturers of single-use bioreactors are currently working with companies that have a vaccine in development or already in the clinical test phases. This is contributing to the growth of the SUB market at these harsh times but at a lower level.
However, factors such as high capital investment, regular recurring expenses for single-use bioreactors, drop in biologics sales due to the COVID-19 outbreak and high costs involved in proper waste management of the vast amounts of disposables hinder the growth of this market.
SINGLE USE BIOREACTORS MARKET SEGMENTATION:
- Single-use Bioreactor Systems
- Up to 10L
- Above 1500L
- Single-use Media Bags
- 2D Bags
- 3D Bags
- Other Bags
- Single-use Filtration Assemblies
- Single-Use Vessels
- Tubing and Connectors
- Stirred-tank SUBs
- Wave-induced SUBs
- Bubble-column SUBs
- Hybrid Bioreactors
By Cell Type:
- Mammalian Cells
- Bacterial Cells
- Yeast Cells
- Insect Cells
- Plant Cells
By Molecule Type:
- Monoclonal Antibodies
- Gene-modified cells
- Stem Cells
- Recombinant Proteins
- Research and Development (R&D)
- Process Development
By End User:
- Pharmaceutical & Biopharmaceutical Companies
- CROs & CMOs
- Academic & Research and Development Institutes
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
The North American region currently dominates and is the largest regional market in the single use bioreactors industry. This is because of the presence of established biopharmaceutical companies and the presence of major players operating in the single-use bioreactors market in the region. The key contributor in the region is the U.S.
The Asia-Pacific region on the other hand is the fastest growing regional market. This is attributed to factors including the continuously growing economies in the region, rapidly increasing population, increasing adoption of latest technologies and growing awareness regarding advantages of single-use bioreactors, rising public & private funding for R&D, rising contract research and manufacturing activities, growing government initiatives to escalate the drug development process, growing number of CROs and CMOs in several countries in the region. The major contributors in the region are India, China and Japan.
The European region is the second largest regional market in the global single-use bioreactors market owing to the presence of established pharmaceutical companies in the region, supportive guidelines influencing biopharmaceutical firms and companies to emerge with new products and services, the increasing usage in cell culture-supported production in the region and several other factors.
FEW KEY PLAYERS IN SINGLE USE BIOREACTORS MARKET:
- Sartorius Stedim Biotech
- Thermo Fisher Scientific
- Danaher Corporation
- Merck Millipore
- Parker Hannifin Corporation
- GE Healthcare
- PBS Biotech
- Applikon Biotechnology
- Celltainer Biotech
- Solida Biotech.
- ABEC Inc.
- Distek Inc.
- OmniBRx Biotechnologies
- Pall Corporation
- Solaris Biotechnology SRL
- Cellexus Ltd
- CESCO Bioengineering Co. Ltd.
- Pierre Guerin Technologies
- Infors AG
- Other Players
- In January 2020, Contract development and manufacturing organization (CDMO), Stelis BioSource, a division of Stelis Biopharma Pvt. Ltd. started the next phase of its continued investment program after having already invested well over $100 million into its facilities in Bangalore, India.
- In November 2020, AGC Biologics announced the increase in their production capacity of its Copenhagen facility. The total investment for this expansion is estimated to be around €160M, and the start of operation is scheduled for 2023.
Timeline Considered for Analysis:
- 2019: Base Year
- 2020 to 2025: Forecast Period
Research Scope and Deliverables
Overview & Executive Summary
Market Drivers, Trends, Challenges and Opportunities
Market Size and Forecast Projections
Macroeconomic Indicators of Various Countries Impacting the Growth of the Market
Extensive Coverage of Industry Players including Recent Product Launches and Market Activities
Porter’s Five Force Analysis
Market Segmentation Analysis:
Industry report analyzes the global single use bioreactors market by the following segments:
- Cell Type
- Molecule Type
- End User
Customization: We also offers customization’s in the industry report as per the company’s specific needs.
Key Questions Answered in the Global Single Use Bioreactors Industry Report
- What is the overall market size in 2019? What will be the market growth during the forecast period i.e. 2020-2025?
- Which region would have high demand for product in the upcoming years?
- What are the factors driving the growth of the market?
- Which sub-market will make the most significant contribution to the market?
- What are the market opportunities for existing and entry-level players?
- What are various long-term and short-term strategies adopted by the market players?